SFM
ACIU icon

Sphera Funds Management’s AC Immune ACIU Stock Holding History

Sphera Funds Management’s Portfolio ACIU Stock Details ACIU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-121,019
Closed -$812K – 91
2021
Q3 		$812K Buy
+121,019
New +$866K 0.07% 106
2019
Q1 		– Sell
-310,613
Closed -$2.94M – 106
2018
Q4 		$2.94M Sell
310,613
-192,950
-38% -$1.82M 0.33% 64
2018
Q3 		$4.03M Buy
+503,563
New +$5.06M 0.46% 64
2016
Q4 		– Sell
-79,800
Closed -$1.31M – 106
2016
Q3 		$1.31M Buy
+79,800
New +$1.38M 0.21% 89

Other funds holding ACIU

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Sphera Funds Management's ACIU Position: Q4 2021 in Review

Sphera Funds Management sold out of AC Immune (ACIU) in Q4 2021, closing a stake of 121,019 shares — an estimated $812K sold.

Sphera Funds Management first reported a position in ACIU in Q3 2016 and held it in 4 quarters. The position peaked at $4.03M in Q3 2018. 44 funds tracked by Wall St. Rank hold ACIU as of Q4 2021.

  • Sphera Funds Management reported no remaining AC Immune position as of Q4 2021 after selling out during the quarter.
  • Sphera Funds Management sold 121,019 AC Immune shares in Q4 2021, an estimated $812K.
  • Sphera Funds Management first reported a position in AC Immune in Q3 2016 and held it in 4 quarters.
  • Sphera Funds Management's AC Immune position peaked at $4.03M in Q3 2018.
  • 44 funds tracked by Wall St. Rank held AC Immune as of Q4 2021.

Based on Sphera Funds Management's 13F filing for Q4 2021, filed 14 Feb 2022.